MD Anderson welcomes 15 volunteer board members, honors two new Life Members
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) has named 15 new members and bestowed its highest honor of Life Member on senior members Regina Rogers of Beaumont and Melvyn N. Klein of Corpus Christi.
Effective Sept. 1, the following business and community leaders join the BOV, a nonfiduciary, appointed advisory board established in 1956:
Syed Javaid Anwar, Midland: president and chief executive...
Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and...
$24 million in CPRIT funding awarded to MD Anderson and related research
The University of Texas MD Anderson Cancer Center today was awarded nearly $9 million from the Cancer Prevention and Research Institute...
Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations
In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in patients with cholangiocarcinoma marked by the BRAF V600E mutation.
This trial represents the first prospective study for patients with BRAF-mutated cholangiocarcinoma, or bile duct cancer, and suggests...
Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
Two different types of detectable antibody responses in SARS-CoV-2 (COVID-19) tell very different stories and may indicate ways to enhance...
Combination therapy significantly improves survival outcomes for patients with acute myeloid leukemia
A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients...
Cancer care and screenings must remain a priority during COVID-19
The University of Texas MD Anderson Cancer Center is committed to safely providing patient care and cancer screenings throughout the novel...